to determine the toxicity , cr rate , and patient survival of m-bacod ( methotrexate , bleomycin , doxorubicin , cyclophosphamide , vincristine , dexamethasone ) , promace-cytabom ( prednisone , methotrexate , doxorubicin , cyclophosphamide , etoposide , cytarabine , bleomycin , vincristine , methotrexate ) , and macop-b ( methotrexate , doxorubicin , cyclophosphamide , vincristine , prednisone , bleomycin ) , swog initiated a series of phase ii studies .
C0279852
macop-b
C0032952
prednisone